Time dependent changes in the individual domains of the SGRQ. Results of the TORCH trial
P. Jones, P. Calverley, B. Celli, J. Anderson, G. Ferguson, C. Jenkins, J. Yates, J. Vestbo (London, Liverpool, Greenford, Manchester, United Kingdom; Boston, MA, Livonia, MI, RTP, NC, United States Of America; Sydney, Australia)
Source: Annual Congress 2007 - New insights into the treatment of COPD
Session: New insights into the treatment of COPD
Session type: Thematic Poster Session
Number: 3583
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Jones, P. Calverley, B. Celli, J. Anderson, G. Ferguson, C. Jenkins, J. Yates, J. Vestbo (London, Liverpool, Greenford, Manchester, United Kingdom; Boston, MA, Livonia, MI, RTP, NC, United States Of America; Sydney, Australia). Time dependent changes in the individual domains of the SGRQ. Results of the TORCH trial. Eur Respir J 2007; 30: Suppl. 51, 3583
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Determinants of the relationship between changes in FEV1 and SGRQ: analysis of the TORCH data Source: Annual Congress 2008 - COPD Year: 2008
Improving morning activities in COPD patients with budesonide/formoterol: Assessment of data from two randomised trials using minimal important differences from a morning activities questionnaire Source: Annual Congress 2010 - Combination therapy in asthma and COPD Year: 2010
Predicting SGRQ score based on CAT score: post-hoc analysis of the IMPACT trial Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021
Comparison of individual items of COPD Assessment Test (CAT) at baseline in the EMAX and IMPACT trials Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020
Breath Holding Time in uncontrolled Asthma: associations with key physiological tests and patient-reported outcome measures Source: International Congress 2019 – Exercise and physiotherapy in patients with asthma, cystic fibrosis, bronchiectasis and primary ciliary dyskinesia Year: 2019
Disease awareness in COPD: Analyses of clinical parameters and patient-reported outcome from the SAT study Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020
Correlations between SGRQ and other clinical and functional parameters in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 809s Year: 2006
Changes in quality of life as assessed by St. Georges respiratory questionnaire (SGRQ) and COPD assessment test (CAT) and spirometric indices in patients with smoker-COPD(S-COPD) and non-smoker-COPD(NS-COPD) after 1 year of follow up Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014
Comparison of outcomes of the Actigraph and the Dynaport activity monitor in patients with COPD; results from PROactive Source: Annual Congress 2012 - Outcomes and assessment methods in physiotherapy and rehabilitation Year: 2012
Do changes in spirometric indices and FeNO predict asthma outcomes in children? An individual patient data analysis using results from seven FeNO trials Source: International Congress 2018 – Primary ciliary dyskinesia and lung function tests in respiratory morbidities Year: 2018
Relationship between exacerbation frequency and quality of life using the airways questionnaire 20 (AQ20) in a randomised controlled trial Source: Eur Respir J 2005; 26: Suppl. 49, 715s Year: 2005
Value of measuring SGRQ at stable phase of COPD to predict the timing and deterioration associated with next exacerbation: the MOSAIC study Source: Eur Respir J 2004; 24: Suppl. 48, 240s Year: 2004
Characterization of exercise impairment in relation to quality of life (QoL) and hospital admission in COPD patients; data from the INTERCOM trial Source: Eur Respir J 2005; 26: Suppl. 49, 433s Year: 2005
COPD exacerbations significantly impact quality of life as measured by SGRQ-C total score: results from the FLAME study Source: International Congress 2017 – Novel mechanisms and treatments for COPD Year: 2017
COPD eDiary compliance: Comparison of age, symptom score, duration in clinical trial and country of origin Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010
Assessing asthma control using a composite measure based on GINA/NIH guidelines: an analysis of GOAL baseline data Source: Eur Respir J 2002; 20: Suppl. 38, 47s Year: 2002
Determining SGRQ and TDI responder rates across the duration of clinical trials: Results from tiotropium + olodaterol in COPD Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017
Quality of life in patients with COPD. Results of EPIDEPOC study Source: Eur Respir J 2005; 26: Suppl. 49, 718s Year: 2005
Patients‘ perception of their own influence on asthma (locus of control). Results from an observational study Source: Eur Respir J 2007; 30: Suppl. 51, 147s Year: 2007